CurrentEndo
Get Weekly

CurrentEndo coverage · page 22 of 33

Cardiovascular Diabetology

Briefs 841–880 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

  1. Cardiovasc Diabetol

    The predictive value of lesion-specific pericoronary fat attenuation index for major adverse cardiovascular events in patients with type 2 diabetes

    Cohort studyT2D & other

  2. Cardiovasc Diabetol

    High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study

    Cohort study

  3. Cardiovasc Diabetol

    Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease

    Cohort studyLipids & liver

  4. Cardiovasc Diabetol

    Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

    Cohort studyLipids & liver

  5. Cardiovasc Diabetol

    Is GFR decline induced by SGLT2 inhibitor of clinical importance?

    Randomized controlled trialT2D & other

  6. Cardiovasc Diabetol

    Correlation between the triglyceride-glucose index and left ventricular global longitudinal strain in patients with chronic heart failure: a cross-sectional study

    Cross-sectional studyLipids & liver

  7. Cardiovasc Diabetol

    Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: “INSIST” study

    Cohort studyT2D & other

  8. Cardiovasc Diabetol

    Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study

    Case-control study

  9. Cardiovasc Diabetol

    Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults

    Cohort studyLipids & liver

  10. Cardiovasc Diabetol

    Association of stress hyperglycemia ratio with left ventricular function and microvascular obstruction in patients with ST-segment elevation myocardial infarction: a 3.0 T cardiac magnetic resonance study

    Cross-sectional study

  11. Cardiovasc Diabetol

    Abnormal vascular thickness and stiffness in young adults with type 1 diabetes: new insights from cutting-edge ultrasound modalities

    Cohort studyT1D

  12. Cardiovasc Diabetol

    Triglyceride-glucose index and health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies

    Meta-analysis

  13. Cardiovasc Diabetol

    Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials

    Secondary analysisT2D & other

  14. Cardiovasc Diabetol

    Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease

    Secondary analysisLipids & liver

  15. Cardiovasc Diabetol

    Association of triglyceride glucose index and triglyceride glucose-body mass index with sudden cardiac arrest in the general population

    Cohort studyLipids & liver

  16. Cardiovasc Diabetol

    Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity

    Mechanistic studyLipids & liver

  17. Cardiovasc Diabetol

    Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome

    Cohort studyLipids & liver

  18. Cardiovasc Diabetol

    Association between the triglyceride–glucose index and all-cause and CVD mortality in the young population with diabetes

    Cohort studyT2D & other

  19. Cardiovasc Diabetol

    Association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute coronary syndrome: results from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome project

    Cohort study

  20. Cardiovasc Diabetol

    The association between the triglyceride–glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study

    Cross-sectional studyT2D & other

  21. Cardiovasc Diabetol

    Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment

    Randomized controlled trialT2D & other

  22. Cardiovasc Diabetol

    Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies

    Cohort studyT2D & other

  23. Cardiovasc Diabetol

    Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease

    Cohort studyLipids & liver

  24. Cardiovasc Diabetol

    Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning

    Cohort study

  25. Cardiovasc Diabetol

    Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease

    Cohort study

  26. Cardiovasc Diabetol

    Association between the triglyceride-glucose index and subclinical left ventricular systolic dysfunction in obese patients

    Cross-sectional studyObesity

  27. Cardiovasc Diabetol

    Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

    Research articleT2D & other

  28. Cardiovasc Diabetol

    SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study

    Research articleT2D & other

  29. Cardiovasc Diabetol

    Cross-sectional and longitudinal associations of Iron biomarkers and cardiovascular risk factors in pre- and postmenopausal women: leveraging repeated measurements to address natural variability

    Cross-sectional studyReproductive endocrine

  30. Cardiovasc Diabetol

    Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: a multicenter population-based study

    Cohort study

  31. Cardiovasc Diabetol

    Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study

    Cohort study

  32. Cardiovasc Diabetol

    Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study

    Cohort study

  33. Cardiovasc Diabetol

    Insulin sensitivity estimates and their longitudinal association with coronary artery disease in type 1 diabetes. Does it matter?

    Cohort studyT1D

  34. Cardiovasc Diabetol

    Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study

    Diagnostic or prognostic studyT2D & other

  35. Cardiovasc Diabetol

    The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged ≥ 60 years: a population-based study

    Cross-sectional studyLipids & liver

  36. Cardiovasc Diabetol

    Association of the triglyceride-glucose index with early-onset atherosclerotic cardiovascular disease events and all-cause mortality: a prospective cohort study

    Cohort study

  37. Cardiovasc Diabetol

    Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI

    Cohort studyT2D & other

  38. Cardiovasc Diabetol

    The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes

    Cohort studyT2D & other

  39. Cardiovasc Diabetol

    Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus

    Mechanistic studyT2D & other

  40. Cardiovasc Diabetol

    Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial

    Secondary analysisT2D & other

All 1,291 Briefs in ExploreShowing Briefs 841–880 of 1,291, newest first